Clinical Trial Update: Study of Talabostat and Cisplatin in Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating talabostat in combination with cisplatin for advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Talabostat (talabostat)

Snippet

Sponsor: Point Therapeutics | Conditions: Melanoma, Skin Cancer | Phase 2 | Status: COMPLETED